Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01698905 · BASELINE

Baseline characteristics

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop) · Source last updated 2026-08-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      163
    units
    Participants
groups
  1. description
    Patients with minimum 3 years of tyrosine kinase inhibitor treatment (first with imatinib and then switched to nilotinib) since initial diagnosis, at least 2 years of nilotinib treatment prior to study entry and who achieved MR4.5 (local laboratory assessment) during nilotinib treatment, and determined by a Novartis designated central PCR lab assessment at screening
    id
    BG000
    title
    NTCS Phase
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          13.99
          value
          54.3
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          86
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          77
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          127
      title
      Caucasian
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      Black
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          23
      title
      Asian
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Native American
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      Other
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      163
    units
    Participants
groups
  1. description
    Patients with minimum 3 years of tyrosine kinase inhibitor treatment (first with imatinib and then switched to nilotinib) since initial diagnosis, at least 2 years of nilotinib treatment prior to study entry and who achieved MR4.5 (local laboratory assessment) during nilotinib treatment, and determined by a Novartis designated central PCR lab assessment at screening
    id
    BG000
    title
    NTCS Phase
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          13.99
          value
          54.3
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          86
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          77
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          127
      title
      Caucasian
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      Black
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          23
      title
      Asian
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Native American
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      Other
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice